Brain Tau Imaging: Food and Drug Administration Approval of <sup>18</sup>F-Flortaucipir Injection
Venkata S. Mattay, Anthony F. Fotenos, Charles J. Ganley, Libero Marzella
Abstract
Alzheimer disease (AD) is the most common of neurodegenerative dementias. Currently, there are more than 5.8 million Americans with AD. Worldwide, there are at least 50 million people with AD or other dementias, and these numbers are projected to triple by 2050 ([1][1]). Timely and accurate
Topics & Concepts
Food and drug administrationMedicineAlzheimer's diseaseDiseaseDrugAdministration (probate law)PediatricsPsychiatryPharmacologyInternal medicinePolitical scienceLawAlzheimer's disease research and treatmentsComputational Drug Discovery MethodsTryptophan and brain disorders